Re: RELMADA CEO Sergio Traversa files Form 4P for 200,000 shares
RELMADA THERAPEUTICS, INC. disclosed via Form 4P that CEO Sergio Traversa reported a transaction involving 200,000 shares at $4.14 each, totaling $828,000.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.